Canada’s ban on marijuana was effectively upheld when Ontario’s top court struck down the country’s laws related to medicinal pot much to the chagrin of activist groups. In overturning a lower court ruling, the Court of Appeal ruled the trial judge had made numerous errors in striking down the country’s medical pot laws. The Appeal Court found the judge was wrong to interpret an earlier ruling as creating a constitutional right to use medical marijuana. Doctors are allowed to exempt patients from the ban on marijuana, but many physicians refuse to prescribe on the grounds its benefits are not scientifically proven.
The Czech Senate approved a bill allowing for the legal sale of cannabis for medical purposes, affirming a decision of the country’s lower house of parliament. The proposal, which enjoys very strong support from all political parties in both houses of parliament, should become law later this year, pending an expected presidential signature. But there’s a catch: the text of the bill says that only imported cannabis will be allowed for sale in the first year “to ensure standards.”
A pro-marijuana group lost its legal battle when a federal appellate court ruled that marijuana would remain a Schedule I drug, defined as having no accepted medical value and a high potential for abuse. For years, the U.S. Drug Enforcement Administration and the National Institute for Drug Abuse have made it all but impossible to develop a robust body of research on the medical uses of marijuana. For a muscular agency that combats vicious drug criminals, the DEA acts like a terrified and obstinate toddler when it comes to basic science.
Marijuana will continue to be considered a highly dangerous drug under federal law with no accepted medical uses, after a U.S. appeals court refused to order a change in the government's 40-year-old drug classification schedule. The decision keeps in place an odd legal split over marijuana, a drug deemed to be as dangerous as heroin and worse than methamphetamine by federal authorities, but one that has been legalized for medical use by voters or legislators in 20 states and the District of Columbia.
In a case that highlights the growing clash between the federal government and those states that have legalized marijuana for medical or recreational use, the United States Justice Department indicted Matthew R. Davies six months ago on charges of cultivating marijuana, after raiding two dispensaries and a warehouse filled with nearly 2,000 marijuana plants. The case illustrates the struggle states and the federal government are now facing as they seek to deal with the changing contours of marijuana laws and public attitudes toward the drug.
A federal magistrate judge ruled that a medical-marijuana dispensary that bills itself as the world's largest can continue to operate, at least for now, in Oakland and San Jose despite a bid by federal prosecutors to shut it down. The ruling marks the latest move in a tug-of-war between local and federal authorities over medical marijuana dispensaries. The judge ruled that the government, not the landlords, must move to evict Harborside for its alleged violation of the federal Controlled Substances Act. (See als: Landlord can’t shut down nation’s largest pot shop, judge says)
Vigorous regulation of a thriving medical-marijuana industry in Colorado offers the best glimpse of what is coming to Washington when it launches its voter-approved social-use market. With continuous surveillance, bar-coded plants and strict financial background checks, Colorado's rules allowed capitalism to be unleased, creating an instant $200 million industry. With retail prices — averagingabout $7.50 a gram — among the cheapest in the country.